In addition, we inhibited PI3K in GBM cells by wortmannin and observed that Akt phosphorylation was restored to a greater level in TRIB1 overexpression cells suggesting that TRIB1 may confer resistance to P13K inhibitory therapies. This evidence concerns the gene AKT1 and glioblastoma.